Back to AG Adage Capital Partners GP, L.L.C.
XENE
Showing 8 of 31 quarters
Position history for AGAdage Capital Partners GP, L.L.C.'s holdings in Xenon Pharmaceuticals Inc.
Yes. Adage Capital Partners GP holds 300,000 shares of XENE (Xenon Pharmaceuticals), worth $18.1M, as of its Q2 2026 13F filing. It reduced the position by 170,000 shares (-36.2%) from Q1 2026. Adage Capital Partners GP has held XENE in every 13F on record since Q4 2018, 31 quarterly filings.
Current Value
$18.1M
Current Shares
300,000
Total Value Change
-$63.9M
Total Shares Change
-1.8M
Quarter-by-Quarter History